Common use of Certification of Completion Clause in Contracts

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical Center. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st of the residency year. • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion of all R1 goals/objectives with a status of achieved by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 50% of the objectives having a status as achieved. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year • Completion of inpatient anticoagulation certification by October 31 of residency year. • Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. • Assigned projects (MUE, drug review, class review, and management project) have been completed • Presentation of at least one major CME program. • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center Geisinger such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical CenterGeisinger. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st within one hundred and twenty (120) days of the residency yearResidents hire date . • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion of all R1 goals/objectives with a status of achieved Achieved for Residency by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 5075% of the objectives having a status as achievedof Achieved for Residency. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year all outpatient competency exams per plan • Completion of inpatient outpatient anticoagulation certification by October 31 August 30 of residency year. • Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. • Assigned projects (MUE, drug review, class review, and management project) have been completed • Presentation of at least one major CME program. • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center Geisinger such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical CenterXxxxxxxxx. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st within 120 days from start of the residency yearhire. • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion 100% of all R1 goals/objectives with a status of achieved for residency by the end of the residencyprogram. Completion of 100% of the remaining goals/objectives for the program with at least 5075% of the objectives having a status as achievedachieved for residency. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year • Completion of inpatient outpatient anticoagulation certification by October 31 end of residency year. Anticoagulation rotation • Completion/passing grade on MTDM certification exams by 12/1 • Completion of major research project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. • Assigned projects (MUE, drug review, class review, Caresite project and management project) have been completed • Presentation of at least one major CME program. • Completion of 1 medication safety update and 1 medication safety project • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center Xxxxxxxxx such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical CenterXxxxxxxxx. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st of the residency year. • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion of all R1 goals/objectives with a status of achieved by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 5075% of the objectives having a status as achieved. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year • Completion of inpatient anticoagulation certification by October 31 of residency year. • Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. • Assigned projects (MUE, drug review, class review, and management project) have been completed • Presentation of at least one major CME program. • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center Xxxxxxxxx such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical CenterXxxxxxxxx. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st within one hundred and twenty (120) days of the residency yearResidents hire date . • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion of all R1 goals/objectives with a status of achieved Achieved for Residency by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 5075% of the objectives having a status as achievedof Achieved for Residency. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year all outpatient competency exams per plan • Completion of inpatient outpatient anticoagulation certification by October 31 August 30 of residency year. • Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. • Assigned projects (MUE, drug review, class review, and management project) have been completed • Presentation of at least one major CME program. • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center Xxxxxxxxx such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical CenterXxxxxxxxx. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer chief executive officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st of the residency year. • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion of all R1 goals/objectives with a status of achieved by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 5075% of the objectives having a status as achieved. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year • Completion of inpatient anticoagulation certification by October 31 of residency year. DRAFT • Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RACOncRAC. • Assigned projects (MUE, 2 drug review, class review, and management project) have been completed • Presentation of at least four major presentations, at the determination of the RPD, with at least one major CME programbeing CE programing. • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center Xxxxxxxxx such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical CenterXxxxxxxxx. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer chief executive officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st of the residency year. • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion of all R1 goals/objectives with a status of achieved by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 5075% of the objectives having a status as achieved. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year DRAFT • Completion of inpatient anticoagulation certification by October 31 of residency year. • Completion of stroke and code certification by October 31 of the residency year. • Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. • Assigned projects (MUE, 2 drug reviewreviews, class review, and management project) have been completed • Presentation of at least one major CME program. • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical Center. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer chief executive officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: •  Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st of the residency year. •  Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions •  Completion of all R1 goals/objectives with a status of achieved by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 50% of the objectives having a status as achieved. All objectives must have a minimum status of satisfactory progress. •  All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement •  Completion of pharmacokinetic certification by October 31 of residency year •  Completion of inpatient anticoagulation certification by October 31 of residency year. •  Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. •  Assigned projects (MUE, drug review, class review, and management project) have been completed •  Presentation of at least one major CME program. •  Completion of minimum staffing requirements as described in section 2.7 •  Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center Xxxxxxxxx such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical CenterXxxxxxxxx. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st within 120 days from start of the residency yearhire. • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion 100% of all R1 goals/objectives with a status of achieved for residency by the end of the residencyprogram. Completion of 100% of the remaining goals/objectives for the program with at least 5075% of the objectives having a status as achievedachieved for residency. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year • Completion of inpatient outpatient anticoagulation certification by October 31 end of residency year. Anticoagulation rotation • Completion/passing grade on MTDM certification exams by 12/1 • Completion of major research project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. • Assigned projects (MUE, drug review, class review, Caresite project and management project) have been completed • Presentation of at least one major CME program. • Completion of 1 medication safety update and 1 medication safety project • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical Center. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: •  Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st of the residency year. •  Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions •  Completion of all R1 goals/objectives with a status of achieved by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 50% of the objectives having a status as achieved. All objectives must have a minimum status of satisfactory progress. •  All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement •  Completion of pharmacokinetic certification by October 31 of residency year •  Completion of inpatient anticoagulation certification by October 31 of residency year. •  Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RAC. •  Assigned projects (MUE, drug review, class review, and management project) have been completed •  Presentation of at least one major CME program. •  Completion of minimum staffing requirements as described in section 2.7 •  Adherence to the organization’s attendance standards and as described in this document under Exhibit A.

Certification of Completion. Certification of completion of the program will be contingent upon Resident successfully completing the core requirements of the Program, returning all property of the Medical Center Xxxxxxxxx such as books, equipment, etc., and having settled any other professional or financial obligations to the Medical CenterXxxxxxxxx. The certificate will be issued in accordance with the provisions of the ASHP Regulations on Accreditation of Pharmacy Residencies and signed by the RPD and the Chief Executive Officer chief executive officer of the organization. A certificate will not be issued to anyone who does not complete the program’s requirements. Core requirements to successfully complete the program include: • Possess a valid pharmacist license from the Pennsylvania State Board of Pharmacy by October 31st of the residency year. • Successful completion of core learning experiences and required longitudinal learning experiences as defined in the learning experience descriptions • Completion of all R1 goals/objectives with a status of achieved by the end of the residency. Completion of 100% of the remaining goals/objectives for the program with at least 5075% of the objectives having a status as achieved. All objectives must have a minimum status of satisfactory progress. • All evaluations must be completed in accordance with ASHP Accreditation Standard as outlined in the Resident Agreement • Completion of pharmacokinetic certification by October 31 of residency year • Completion of inpatient anticoagulation certification by October 31 of residency year. • Completion of major project, which includes meeting all project deadlines and submission of written manuscript of completed project to the RACOncRAC. • Assigned projects (MUE, 2 drug review, class review, and management project) have been completed • Presentation of at least four major presentations, at the determination of the RPD, with at least one major CME programbeing CE programing. • Completion of minimum staffing requirements as described in section 2.7 • Adherence to the organization’s attendance standards and as described in this document under Exhibit A.